Anna Farago
Vice President, Early Development Oncology Amgen Inc.
Seminars
Thursday 17th September 2026
Advancing Tarlatamab in SCLC: From Second-Line Approval to Frontline & Combination Strategies
4:00 pm
- Details to be announced
